SEC Form 4 · accession 0000939767-18-000002

EXELIXIS, INC. · EXEL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 8, 2018

Accepted (ET)

Jan 10, 2018 · 7:27 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000939767

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 8, 2018	M	3,500	$7.97	A	64,829	D
Common Stock^F2	Jan 8, 2018	S	3,500	$31.29	D	61,329	D
Common Stock	Jan 9, 2018	M	11,500	$7.97	A	72,829	D
Common Stock	Jan 9, 2018	S	11,500	$30.00	D	61,329	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F3	$7.97	Jan 8, 2018	M	3,500	D	May 2, 2009	May 1, 2018	Option (right to buy)	3,500	11,500	D
Option (right to buy)^F3	$7.97	Jan 9, 2018	M	11,500	D	May 2, 2009	May 1, 2018	Option (right to buy)	11,500	0	D

F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2017.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.51. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2009.

Exhibit List: Exhibit 24 - Power of Attorney